Tirzepatide: A Dual-Action Approach to Weight Management Tirzepatide represents a newer advancement in GLP-1 therapy because it activates two hormone pathways simultaneouslyGLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Some people tolerate these effects, while others may need dose adjustments or may stop treatment during a trial
You may see more puffiness or bloating in the first 4-6 weeks before it levels off
PlexusDx recommends keeping a simple fatigue log noting energy level (110 scale), meal composition, water intake, and sleep hours for one week
This feeling of fullness is especially helpful for people trying to lose weight
Reducing overall exposure is a reasonable goal, and it is worth discussing alongside diet, folic acid, and antioxidant intake with your provider